OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuropsychiatric aspects of long COVID: A comprehensive review
Takafumi Kubota, Naoto Kuroda, Daichi Sone
Psychiatry and Clinical Neurosciences (2022) Vol. 77, Iss. 2, pp. 84-93
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID
Jingwei Li, Yun Zhou, Jiechao Ma, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 57

Experiencias de las personas con sintomatología neuropsicológica de covid persistente en Cataluña: un estudio fenomenológico
Eduard Moreno‐Gabriel, Jofre Bielsa-Pascual, Maria Verdaguer, et al.
Atención Primaria (2025) Vol. 57, Iss. 6, pp. 103214-103214
Closed Access | Times Cited: 1

SARS-CoV-2 and the nervous system: current perspectives
Amrita Pattanaik, Sushma Bhandarkar B, Lonika Lodha, et al.
Archives of Virology (2023) Vol. 168, Iss. 6
Open Access | Times Cited: 33

Sleep and memory complaints in long COVID: an insight into clustered psychological phenotypes
Ricardo Titze‐de‐Almeida, Pedro Lacerda, Edson Pereira de Oliveira, et al.
PeerJ (2024) Vol. 12, pp. e16669-e16669
Open Access | Times Cited: 7

Long COVID in Children, Adults, and Vulnerable Populations: A Comprehensive Overview for an Integrated Approach
Valeria Calcaterra, Sara Zanelli, Andrea Foppiani, et al.
Diseases (2024) Vol. 12, Iss. 5, pp. 95-95
Open Access | Times Cited: 7

Cortical thickness alterations and systemic inflammation define long-COVID patients with cognitive impairment
Bianca Besteher, Tonia Rocktäschel, Alejandra P. Garza, et al.
Brain Behavior and Immunity (2023) Vol. 116, pp. 175-184
Open Access | Times Cited: 20

Longterm course of neuropsychological symptoms and ME/CFS after SARS-CoV-2-infection: a prospective registry study
Philipp A. Reuken, Bianca Besteher, Kathrin Finke, et al.
European Archives of Psychiatry and Clinical Neuroscience (2023)
Open Access | Times Cited: 16

Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis
Krystyna Taylor, Matthew Pearson, Sayoni Das, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 16

Multi-target drugs for the treatment of cognitive impairment and fatigue in post-COVID syndrome: focus on Ginkgo biloba and Rhodiola rosea
Juliane K. Mueller, Walter E. Müller
Journal of Neural Transmission (2024) Vol. 131, Iss. 3, pp. 203-212
Open Access | Times Cited: 5

Ocular neuroinflammatory response secondary to SARS-CoV-2 infection-a review
Yun Zhao, Ying Tang, Qi Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Prevalence and Factors Associated with Common Mental Disorders and Posttraumatic Stress Disorder Among Healthcare Workers in a Reference Center for Infectious Diseases During the COVID-19 Pandemic: A Survey-Based Cross-Sectional Study
Patrícia Guimarães, Raquel de Vasconcellos Carvalhães de Oliveira, Rocicley Amud, et al.
International Journal of Environmental Research and Public Health (2025) Vol. 22, Iss. 2, pp. 271-271
Open Access

Altered corticostriatal connectivity in long-COVID patients is associated with cognitive impairment
Marie Troll, Meng Li, Tara Chand, et al.
Psychological Medicine (2025) Vol. 55
Closed Access

Effects of Nirmatrelvir/ritonavir (paxlovid) on the nervous system: analysis on adverse events released by FDA
Caixia Gao, Zhihui Liu, Zhen Zou, et al.
Expert Opinion on Drug Safety (2025), pp. 1-8
Closed Access

The role of esketamine in persistent long COVID with predominant psychiatric manifestations
Ina Bozic, Dominik Ivkic, Lutz Reinfried, et al.
European Neuropsychopharmacology (2025) Vol. 93, pp. 66-67
Closed Access

Neuropsychiatric Symptoms and Psychotropic Medication Use Following SARS-Cov-2 Infection Among Elderly Residents in Long-Term Care Facilities
Diana Cruz-Santiago, Xiangfei Meng, Michelle Canac‐Marquis, et al.
Canadian Geriatrics Journal (2025) Vol. 28, Iss. 1, pp. 67-72
Open Access

Therapeutic Potential of Psilocybin for Treating Neuropsychiatric Long COVID Symptoms: A Reddit Investigation
Lukas Bobak, Ian Dorney, Alexsandra Kovacevich, et al.
Journal of Psychoactive Drugs (2025), pp. 1-9
Closed Access

COVID-19 delirium and encephalopathy: Pathophysiology assumed in the first 3 years of the ongoing pandemic
Kyohei Otani, Haruko Fukushima, Kunitaka Matsuishi
Brain Disorders (2023) Vol. 10, pp. 100074-100074
Open Access | Times Cited: 14

Review of organ damage from COVID and Long COVID: a disease with a spectrum of pathology
Andrew G. Ewing, Špela Šalamon, Etheresia Pretorius, et al.
Medical Review (2024) Vol. 5, Iss. 1, pp. 66-75
Open Access | Times Cited: 4

Cognitive Aspects of COVID-19
Ezekiel Gonzalez‐Fernandez, Juebin Huang
Current Neurology and Neuroscience Reports (2023) Vol. 23, Iss. 9, pp. 531-538
Closed Access | Times Cited: 11

Cognitive Impairment in the Post-Acute Phases of COVID-19 and Mechanisms: An Introduction and Narrative Review
Weiye Wang, Ruxin Cui, Luming Leng, et al.
Journal of Alzheimer s Disease Reports (2024) Vol. 8, Iss. 1, pp. 647-658
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top